As biologics research continues to evolve and gain prominence in therapy development for disease states, the need for reliable and robust cell lines will greatly increase.
Traditionally, cell line development has been achieved manually, limiting it to low-throughput applications and making it susceptible to variability caused by human error and contamination.
Automating the cell line development workflow with
Beckman Coulter Liquid Handlers:
Paul Anderson
Director - Biologics Discovery Automation
Eli Lilly
In this webinar, Paul Anderson, Director - Biologics Discovery Automation at Eli Lilly will focus on the automated systems that have been developed as part of this platform. This highly automated approach to antibody discovery has enabled Lilly to meet aggressive timelines and dramatically increase throughput while allowing flexibility for future changes to its process.
Automation can overcome many cell line development challenges including:
▶ Biomek Automated Workstations enable:
▶ Echo Acoustic Liquid Handlers allow:
The real-world benefits provided by our technologies are realized only through their application.
Learn how other customers are leveraging our solutions to automate their CLD workflows
Explore peer-reviewed publications from leading journals where scientists have cited our solutions in their CLD workflows
View CLD related webinars from highly acclaimed researchers and industry professionals from around the world
SINTEF Industry, Norway discusses the benefits of automating cell line development workflows with Beckman Coulter Liquid Handlers.
Product No: C23340
For high-throughput laboratories, the Biomek i7 Workstation provides a complete walkaway solution to maximize return on investment (ROI).
Product No: 001-10080
For medium- to high-throughput screening applications, the Echo 650 series provides contactless automation to enable scientific discovery.
Product No: 001-10080
For medium- to high-throughput screening applications, the Echo 525 series provides contactless automation to enable scientific discovery
Product No: C23339
For high-throughput laboratories, the Biomek i7 Workstation provides a complete walkaway solution to maximize return on investment (ROI).
Product No: C23341
For medium- to high-throughput laboratories, the Biomek i5 Workstation provides scalable automation that grows with changing workflow needs.
Product No: C23342
For medium- to high-throughput laboratories, the Biomek i5 Workstation provides scalable automation that grows with changing workflow needs.
Access product and portfolio overviews, informational flyers & more to support your CLD workflows
Transform liquid handlers into CLD workflow solutions by integrating more than 300 third-party devices from over 60 manufacturers to develop multi-device robotic system to increase your lab's throughput, accuracy and scalability
See CLD related posters presented by Beckman Coulter scientists at conferences, meetings and symposia around the world
Drive optimum performance, flexibility and scalability on your choice of platforms with our reagent portfolio powered by Solid Phase Reversible Immobilization (SPRI) technology—widely known as the science behind AMPure XP
Get reliable results without the need to learn automation language. Simplify the complexity of sample and data handling through our software package add-ons to meet your CLD workflow needs.
Watch videos that dive into our portfolio of flexible automated liquid handling solutions to automate your CLD workflows
These products are not intended or validated for use in the diagnosis of disease or other conditions. © 2022 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein, including Biomek, are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. Echo and Access are trademarks or registered trademarks of Labcyte Inc. in the United States and other countries. Labcyte is a Beckman Coulter company. All other trademarks are the property of their respective owners.
